30 Years of Continuous Experience and Innovation
Dr. Abidi Pharmaceuticals’ Leading Role in Advancing Gastrointestinal Therapeutics

Exactly 30 years ago, the global medical landscape was revolutionized by the introduction of the first Proton Pump Inhibitor (PPI), offering a highly effective and enduring solution for gastric acid regulation. Concurrently in Iran, Dr. Abidi Pharmaceuticals localized this global breakthrough by manufacturing and launching Merazol®.

Since its inception, Merazol® has established a prominent position among healthcare professionals and patients as a reliable and fundamental therapy for managing Gastroesophageal Reflux Disease (GERD) and associated conditions. To date, over 140 million patients have benefited from Dr. Abidi Pharmaceuticals’ gastrointestinal portfolio, experiencing enhanced relief and improved quality of life amidst GI complications.

A Reliable Solution for the Management of GERD

Globally, 1 in every 5 individuals suffers from acid reflux (GERD). Heartburn, one of the most prevalent symptoms of this condition, typically occurs due to the regurgitation of gastric acid into the esophagus. Regulating gastric acid secretion remains one of the primary therapeutic strategies for treating GERD and preventing severe complications such as esophageal mucosal damage.

Over the past 30 years in Iran, Merazol® has consistently served as an effective and trusted treatment for millions of patients, maintaining its status as one of the physicians’ first-choice therapies for acid-related disorders.

Sustaining Innovation in Gastrointestinal Therapeutics

Building upon the resounding success of Merazol®, Dr. Abidi Pharmaceuticals introduced two additional innovative medications, Ezonium® and Lanzo®, exactly 10 years ago. Formulated utilizing advanced pharmaceutical technologies, these medications established novel standards in the treatment of complex conditions such as Helicobacter pylori (H. pylori) infections and severe GERD. Today, Ezonium® is widely recognized as the first-line treatment for acid secretion disorders across the country.

Unwavering Commitment to Quality and Innovation

With over 30 years of distinguished expertise in developing multiple therapeutic solutions for gastrointestinal management, Dr. Abidi Pharmaceuticals continuously prioritizes quality and innovation.

As we proudly celebrate the 30^th anniversary of Merazol®, we are thrilled to announce that we will soon unveil a groundbreaking new therapeutic solution—taking yet another monumental step toward creating a brighter, healthier future for our community.